Precigen, Inc. - Understand $pgen stock

$PGEN Market Cap: $235.7 Million

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$3.963M

TTM

Gross Margin

-14.71%

TTM

Net Earnings

-$139.6M

TTM

Current Assets

$34.51M

Q3 2024

Current Liabilities

$21.22M

Q3 2024

Current Ratio

162.67%

Q3 2024

Total Assets

$83.47M

Q3 2024

Total Liabilities

$28.10M

Q3 2024

Book Value

$55.38M

Q3 2024

Cash

$24.73M

Q3 2024

P/E

-1.689

Nov 29, 2024 EST

Free Cash Flow

-$84.30M

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Revenue	$6.225M	$26.91M	$103.9M	$103.2M	$90.72M	$151.2M	$231.0M	$190.9M	$173.6M	$71.93M	$23.76M	$13.77M	$8.013M
YoY Change	-76.87%	-74.09%	0.67%	13.73%	-39.99%	-34.55%	20.98%	9.98%	141.35%	202.74%	72.5%	71.9%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Revenue	$6.225M	$26.91M	$103.9M	$103.2M	$90.72M	$151.2M	$231.0M	$190.9M	$173.6M	$71.93M	$23.76M	$13.77M	$8.013M
Cost Of Revenue	$6.119M	$6.339M	$58.39M	$55.50M	$61.40M	$62.70M	$29.53M	$23.93M	$23.18M	$8.225M	$0.00	$0.00
Gross Profit	$106.0K	$20.57M	$45.49M	$47.70M	$29.30M	$88.50M	$201.5M	$167.0M	$150.4M	$63.71M	$23.76M	$13.77M
Gross Profit Margin	1.7%	76.44%	43.79%	46.23%	32.3%	58.54%	87.22%	87.47%	86.65%	88.57%	100.0%	100.0%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Selling, General & Admin	$40.42M	$48.01M	$74.12M	$91.70M	$98.60M	$137.8M	$146.1M	$142.3M	$109.1M	$63.65M	$33.62M	$24.90M	$18.30M
YoY Change	-15.81%	-35.23%	-19.17%	-7.0%	-28.45%	-5.68%	2.66%	30.5%	71.34%	89.33%	35.03%	36.05%
% of Gross Profit	38127.36%	233.38%	162.95%	192.24%	336.52%	155.71%	72.52%	85.22%	72.5%	99.91%	141.49%	180.75%
Research & Development	$48.61M	$47.17M	$50.14M	$0.00	$0.00	$404.6M	$143.2M	$112.1M	$147.5M	$58.98M	$48.14M	$64.03M	$70.23M
YoY Change	3.06%	-5.93%			-100.0%	182.52%	27.71%	-23.97%	150.04%	22.52%	-24.82%	-8.82%
% of Gross Profit	45862.26%	229.31%	110.23%	0.0%	0.0%	457.16%	71.09%	67.15%	98.05%	92.59%	202.62%	464.89%
Depreciation & Amortization	$6.668M	$10.77M	$13.76M	$17.52M	$24.90M	$33.11M	$31.15M	$24.57M	$17.74M	$10.42M	$7.205M	$7.984M	$3.078M
YoY Change	-38.06%	-21.77%	-21.44%	-29.64%	-24.81%	6.32%	26.75%	38.49%	70.36%	44.55%	-9.76%	159.39%
% of Gross Profit	6290.57%	52.33%	30.25%	36.72%	84.97%	37.41%	15.46%	14.71%	11.8%	16.35%	30.32%	57.96%
Operating Expenses	$89.03M	$95.18M	$124.3M	$0.00	$0.00	$666.2M	$368.9M	$316.1M	$320.5M	$141.9M	$81.78M	$88.93M	$90.44M
YoY Change	-6.46%	-23.41%			-100.0%	80.6%	16.7%	-1.37%	125.85%	73.5%	-8.04%	-1.67%
Operating Profit	-$88.92M	-$74.61M	-$78.78M	$47.70M	$29.30M	-$505.6M	-$137.9M	-$125.2M	-$146.9M	-$69.96M	-$58.02M	-$75.16M	-$82.43M
YoY Change	19.19%	-5.29%	-265.15%	62.8%	-105.79%	266.68%	10.17%	-14.77%	109.92%	20.58%	-22.8%	-8.82%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Interest Expense	$2.769M	-$5.779M	-$17.28M	-$17.10M	-$16.20M	$8.530M	$611.0K	$861.0K	$1.244M	$666.0K	$141.0K	$57.00K	$183.0K
YoY Change	-147.91%	-66.55%	1.04%	5.56%	-289.92%	1296.07%	-29.04%	-30.79%	86.79%	372.34%	147.37%	-68.85%
% of Operating Profit				-35.85%	-55.29%
Other Income/Expense, Net	$567.0K	$1.539M	-$330.0K	-$200.0K	$11.70M	-$19.02M	$22.47M	-$47.87M	$68.83M	-$10.50M	$17.72M	-$6.443M	-$2.853M
YoY Change	-63.16%	-566.36%	65.0%	-101.71%	-161.53%	-184.62%	-146.95%	-169.54%	-755.71%	-159.23%	-375.04%	125.83%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Pretax Income	-$96.36M	-$79.97M	-$96.93M	-$103.9M	-$171.3M	-$395.9M	-$78.37M	-$194.2M	-$86.98M	-$85.72M	-$40.91M	-$81.87M	-$85.30M
YoY Change	20.5%	-17.5%	-6.67%	-39.36%	-56.74%	405.2%	-59.64%	123.22%	1.47%	109.54%	-50.04%	-4.02%
Income Tax	-$458.0K	-$189.0K	-$160.0K	-$82.00K	-$930.0K	-$15.43M	$2.072M	-$3.877M	$1.016M	-$103.0K	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$95.90M	$28.32M	-$92.17M	-$170.5M	-$322.3M	-$509.3M	-$117.0M	-$186.6M	-$84.49M	-$81.82M	-$38.98M	-$81.87M	-$85.28M
YoY Change	-438.67%	-130.72%	-45.95%	-47.1%	-36.72%	335.26%	-37.29%	120.86%	3.26%	109.91%	-52.39%	-3.99%
Net Earnings / Revenue	-1540.56%	105.23%	-88.73%	-165.27%	-355.29%	-336.91%	-50.66%	-97.74%	-48.67%	-113.75%	-164.06%	-594.41%	-1064.27%
Basic Earnings Per Share	-$0.39	$0.14	-$0.47	-$1.02	-$2.09
Diluted Earnings Per Share	-$0.39	$0.14	-$0.47	-$1.02	-$2.09	-$3.933M	-$975.0K	-$1.581M	-$760.6K	-$824.6K	-$951.2K	-$14.89M	-$16.40M

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Cash & Short-Term Investments	$62.86M	$55.95M	$115.2M	$100.1M	$75.10M	$216.9M	$79.70M	$237.2M	$238.3M	$116.0M	$177.5M	$10.70M	$19.90M
YoY Change	12.34%	-51.42%	15.04%	33.29%	-65.38%	172.15%	-66.4%	-0.46%	105.43%	-34.65%	1558.88%	-46.23%
Cash & Equivalents	$7.578M	$4.858M	$42.92M	$51.80M	$65.80M	$96.90M	$68.10M	$62.60M	$135.8M	$27.50M	$49.50M	$10.40M	$19.60M
Short-Term Investments	$55.28M	$51.09M	$72.24M	$48.30M	$9.300M	$120.0M	$11.60M	$174.6M	$102.5M	$88.50M	$128.0M	$300.0K	$300.0K
Other Short-Term Assets	$4.325M	$48.12M	$6.736M	$17.10M	$117.2M	$21.40M	$14.10M	$14.40M	$6.600M	$3.800M	$2.700M	$2.200M	$1.800M
YoY Change	-91.01%	614.34%	-60.61%	-85.41%	447.66%	51.77%	-2.08%	118.18%	73.68%	40.74%	22.73%	22.22%
Inventory		$287.0K	$13.26M	$11.40M	$16.10M	$20.60M	$20.50M	$21.10M	$26.60M	$25.80M
Prepaid Expenses
Receivables	$902.0K	$978.0K	$20.91M	$16.50M	$21.30M	$25.30M	$37.70M	$38.40M	$48.70M	$27.20M	$6.100M	$700.0K	$300.0K
Other Receivables	$673.0K	$12.83M	$566.0K	$3.900M	$4.900M	$1.300M	$2.100M	$4.100M	$3.600M	$2.100M	$1.300M	$0.00	$1.000M
Total Short-Term Assets	$68.76M	$118.2M	$156.6M	$148.9M	$234.6M	$285.5M	$154.0M	$315.2M	$323.8M	$174.8M	$187.6M	$13.50M	$23.00M
YoY Change	-41.81%	-24.56%	5.19%	-36.53%	-17.83%	85.39%	-51.14%	-2.66%	85.24%	-6.82%	1289.63%	-41.3%
Property, Plant & Equipment	$14.21M	$15.42M	$45.22M	$44.30M	$86.20M	$86.90M	$112.7M	$64.70M	$42.70M	$38.00M	$16.60M	$18.70M	$18.50M
YoY Change	-7.83%	-65.91%	2.07%	-48.61%	-0.81%	-22.89%	74.19%	51.52%	12.37%	128.92%	-11.23%	1.08%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments		$0.00	$48.56M	$0.00	$1.500M	$2.800M	$189.9M	$182.7M	$199.1M	$195.2M	$208.4M	$88.80M	$39.10M
YoY Change		-100.0%		-100.0%	-46.43%	-98.53%	3.94%	-8.24%	2.0%	-6.33%	134.68%	127.11%
Other Assets	$767.0K	$1.025M	$1.188M	$1.600M	$1.400M	$158.4M	$4.100M	$3.700M	$3.700M	$1.300M	$1.100M	$1.100M	$1.700M
YoY Change	-25.17%	-13.72%	-25.75%	14.29%	-99.12%	3763.41%	10.81%	0.0%	184.62%	18.18%	0.0%	-35.29%
Total Long-Term Assets	$82.29M	$97.82M	$203.2M	$165.7M	$221.2M	$430.7M	$692.9M	$633.9M	$658.2M	$401.5M	$281.9M	$138.1M	$91.80M
YoY Change	-15.88%	-51.87%	22.65%	-25.09%	-48.64%	-37.84%	9.31%	-3.69%	63.94%	42.43%	104.13%	50.44%
Total Assets	$151.0M	$216.0M	$359.9M	$314.6M	$455.8M	$716.2M	$846.9M	$949.1M	$982.0M	$576.3M	$469.5M	$151.6M	$114.8M
YoY Change
Accounts Payable	$1.726M	$4.068M	$5.405M	$4.600M	$5.900M	$12.00M	$8.700M	$8.500M	$5.000M	$6.300M	$1.100M	$600.0K	$3.100M
YoY Change	-57.57%	-24.74%	17.5%	-22.03%	-50.83%	37.93%	2.35%	70.0%	-20.63%	472.73%	83.33%	-80.65%
Accrued Expenses	$20.75M	$31.33M	$24.37M	$20.30M	$30.30M	$29.00M	$27.60M	$22.30M	$27.00M	$13.50M	$9.300M	$6.000M	$5.300M
YoY Change	-33.78%	28.58%	20.04%	-33.0%	4.48%	5.07%	23.77%	-17.41%	100.0%	45.16%	55.0%	13.21%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00	$0.00	$1.900M	$500.0K	$200.0K	$800.0K	$600.0K	$2.300M	$0.00	$0.00	$0.00
YoY Change				-100.0%	280.0%	150.0%	-75.0%	33.33%	-73.91%
Long-Term Debt Due	$0.00	$43.22M	$402.0K	$400.0K	$31.70M	$500.0K	$500.0K	$400.0K	$900.0K	$1.700M	$0.00	$0.00	$100.0K
YoY Change	-100.0%	10651.0%	0.5%	-98.74%	6240.0%	0.0%	25.0%	-55.56%	-47.06%			-100.0%
Total Short-Term Liabilities	$22.99M	$78.65M	$34.65M	$42.10M	$122.9M	$61.60M	$80.20M	$94.60M	$75.90M	$47.50M	$19.80M	$16.70M	$17.60M
YoY Change	-70.77%	127.0%	-17.71%	-65.74%	99.51%	-23.19%	-15.22%	24.64%	59.79%	139.9%	18.56%	-5.11%
Long-Term Debt	$0.00	$0.00	$182.7M	$171.5M	$186.3M	$211.2M	$7.500M	$7.600M	$7.600M	$8.700M	$1.700M	$0.00	$100.0K
YoY Change		-100.0%	6.56%	-7.94%	-11.79%	2716.0%	-1.32%	0.0%	-12.64%	411.76%		-100.0%
Other Long-Term Liabilities	$7.713M	$8.810M	$32.58M	$30.90M	$72.00M	$60.80M	$197.0M	$260.6M	$171.9M	$110.8M	$66.60M	$49.80M	$16.70M
YoY Change	-12.45%	-72.95%	5.42%	-57.08%	18.42%	-69.14%	-24.41%	51.6%	55.14%	66.37%	33.73%	198.2%
Total Long-Term Liabilities	$7.713M	$8.810M	$215.3M	$202.4M	$258.3M	$272.0M	$204.5M	$268.2M	$179.5M	$119.5M	$68.30M	$49.80M	$16.80M
YoY Change	-12.45%	-95.91%	6.39%	-21.64%	-5.04%	33.01%	-23.75%	49.42%	50.21%	74.96%	37.15%	196.43%
Total Liabilities	$32.55M	$89.72M	$252.5M	$247.4M	$384.1M	$353.3M	$313.2M	$388.8M	$288.0M	$191.5M	$102.8M	$66.50M	$34.40M
YoY Change	-63.73%	-64.47%	2.06%	-35.59%	8.72%	12.8%	-19.44%	35.0%	50.39%	86.28%	54.59%	93.31%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2023	2022	2021	2020	2019
Basic Shares Outstanding	244.5M shares	200.4M shares	197.8M shares	167.1M shares	154.1M shares
Diluted Shares Outstanding	244.5M shares	200.4M shares	197.8M shares	167.1M shares	154.1M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Stock Price

Market Cap: $235.73 Million

About PRECIGEN, INC.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. The company is headquartered in Germantown, Maryland and currently employs 202 full-time employees. The company went IPO on 2013-08-08. The Company’s proprietary technology platforms develops product candidates designed to target urgent and intractable diseases in its core therapeutic areas of immuno-oncology, autoimmune disorders and infectious diseases. The company has developed a pipeline of therapies across multiple indications. The firm operates through two segments: Biopharmaceuticals and Exemplar. Biopharmaceuticals segment is primarily comprised of the Company's legal entities of Precigen and ActoBio, as well as royalty interests in therapeutics and therapeutic platforms from companies not controlled by the Company. Exemplar segment is composed of Exemplar Genetics LLC, doing business as Precigen Exemplar (Exemplar), its wholly owned subsidiary focused on developing research models and services for healthcare research applications.

Industry: Pharmaceutical Preparations Peers: ADMA BIOLOGICS, INC. Alaunos Therapeutics, Inc. Allakos Inc. Aura Biosciences, Inc. C4 Therapeutics, Inc. Entrada Therapeutics, Inc. Imago BioSciences, Inc. LEXICON PHARMACEUTICALS, INC. Rallybio Corp